Florida biotech industry leaders call for 'next step'
Representatives from biotechnology research centers in Florida called for more efforts Tuesday from state leaders to help commercialize new products and assist startup companies.
At the Sarasota-based Roskamp Institute, scientists have an experimental drug, Nilvadipine, that has proved successful in preventing the decline of patients who have early Alzheimer's disease.
At the H. Lee Moffitt Comprehensive Canter Center in Tampa, the Moffitt Technologies Corp. has been launched to bring the latest cancer therapies to market.
At the University of Miami, Converge BioTech Inc. has a hybrid cell transplant therapy effective in the treatment of diabetes.
Speakers at the Biotechnology Legislative Caucus outlined these and other advances, but explained that more trained laboratory personnel are needed from community colleges and universities.
|
